| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2024 | MMSI Merit Medical Systems Inc | Peterson Neil51 | Chief Operating Officer | Sell | 5,000 | $98.00 | $490,000.00 | -25.2% | +8.6% | -11.8% | |
| Nov 5, 2024 | MMSI Merit Medical Systems Inc | Parra Raul Jr.62 | CFO And Treasurer | Sell | 29,646 | $98.02 | $2,905,900.92 | -64.4% | +8.6% | -11.8% | |
| Nov 5, 2024 | GEHC Ge Healthcare Technologies Inc. | Rackliffe Philip | CEO, Avs | Sell | 900 | $87.63 | $78,867.00 | -6.6% | -0.7% | -14.2% | |
| Nov 5, 2024 | SYK Stryker Corp | Stryker Ronda E57 | Director, 10% Owner | Sell | 230,000 | $367.37 | $84,494,989.68 | -0.9% | +5.8% | -3.3% | |
| Nov 5, 2024 | TMDX Transmedics Group, Inc. | Basile Edward M64 | Director | Sell | 6,750 | $83.55 | $563,993.80 | -69.8% | -17.2% | +50.0% | |
| Nov 5, 2024 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 162,778 | $84.75 | $13,794,850.92 | -4.8% | +20.5% | +15.6% | |
| Nov 4, 2024 | IRTC Irhythm Holdings, Inc. | Talwalkar Abhijit Y56 | Director | Buy | 6,664 | $75.16 | $500,866.24 | +54.3% | +33.7% | +122.4% | |
| Nov 4, 2024 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 341 | $13.55 | $4,620.55 | -1.5% | +24.9% | +12.6% | |
| Nov 4, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 3,100 | $51.05 | $158,247.08 | -3.5% | -34.2% | -82.4% | |
| Nov 4, 2024 | IRTC Irhythm Holdings, Inc. | Blackford Quentin S.60 | President And CEO | Sell | 16,145 | $77.41 | $1,249,784.45 | -9.2% | +33.7% | +122.4% | |
| Nov 2, 2024 | NVCR Novocure Ltd | Paravasthu Mukund69 | Chief Operating Officer | Sell | 44 | $16.69 | $734.18 | -1.3% | +51.5% | -24.4% | |
| Nov 1, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 1,083 | $82.64 | $89,499.12 | -4.9% | -18.8% | +59.6% | |
| Nov 1, 2024 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 6,983 | $84.33 | $588,876.39 | -17.9% | +23.2% | +20.4% | |
| Nov 1, 2024 | MXCT Maxcyte, Inc. | Erck Stanley C86 | Director | Sell | 47,689 | $3.72 | $177,403.08 | -15.1% | +21.8% | -59.2% | |
| Nov 1, 2024 | NVCR Novocure Ltd | Paravasthu Mukund69 | Chief Operating Officer | Sell | 160 | $15.88 | $2,540.42 | -4.4% | +57.7% | -20.8% | |
| Nov 1, 2024 | NVCR Novocure Ltd | Leonard Frank X76 | EVP, Pres., Novocure Oncology | Sell | 598 | $15.94 | $9,530.74 | -0.4% | +57.7% | -20.8% | |
| Nov 1, 2024 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 69 | $242.00 | $16,698.00 | -0.7% | +5.5% | +1.1% | |
| Nov 1, 2024 | INSP Inspire Medical Systems, Inc. | Rondoni John79 | Chief Technology Officer | Sell | 8,703 | $193.47 | $1,683,730.99 | -14.8% | +2.1% | -62.2% | |
| Nov 1, 2024 | ICUI Icu Medical Inc/de | Jain Vivek83 | Chairman And CEO | Sell | 12,000 | $171.84 | $2,062,136.38 | -2.7% | -2.9% | -29.7% | |
| Nov 1, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 8,657 | $0.71 | $6,128.29 | - | +17.0% | +23.6% | |
| Nov 1, 2024 | SNWV Sanuwave Health, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 27,868 | $15.75 | $438,902.36 | +1.0% | - | - | |
| Oct 31, 2024 | BLFS Biolife Solutions Inc | De Greef Roderick74 | President And CEO | Sell | 46,896 | $23.43 | $1,098,773.28 | -10.2% | +20.9% | +19.1% | |
| Oct 31, 2024 | SSII Ss Innovations International, Inc. | Adams Timothy P. | Director | Buy | 1,399,595 | $1.46 | $2,043,408.70 | +142.6% | - | - | |
| Oct 31, 2024 | SSII Ss Innovations International, Inc. | Srivastava Sudhir | Chairman And CEO | Sell | 1,399,595 | $1.46 | $2,043,408.70 | -1.2% | - | - | |
| Oct 31, 2024 | NVCR Novocure Ltd | Puri Michal Nath | Chief Human Resources Officer | Sell | 810 | $15.79 | $12,791.68 | -0.7% | +68.1% | -15.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.